Speckle Tracking Echocardiography for Detection of Early Myocardial Changes in Patients Treated with Anthracyclines

AUTHORS

Farid Mirzaee 1 , Armin Attar 2 , Mohammad Mohammadianpanah 3 , Firoozeh Abtahi 2 , Fatemeh Amirmoezi 4 , Alireza Moaref 2 , *

1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

2 Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

How to Cite: Mirzaee F , Attar A, Mohammadianpanah M , Abtahi F , Amirmoezi F , et al. Speckle Tracking Echocardiography for Detection of Early Myocardial Changes in Patients Treated with Anthracyclines, Int Cardio Res J. 2017 ; 11(2):e10514.

ARTICLE INFORMATION

International Cardiovascular Research Journal: 11 (2); e10514
Published Online: June 30, 2017
Article Type: Research Article
Received: May 31, 2017
Accepted: January 24, 2017
Crossmark
CHEKING
READ FULL TEXT
Abstract

Background: Anthracyclines, as cancer chemotherapeutic agents, play an undeniable role in treatment of several cancers. As cardiotoxicity is an important adverse reaction of anthracyclines, elucidation of asymptomatic and potentially symptomatic changes in Left Ventricular Ejection Fraction (LVEF) is of significant interest in patients receiving chemotherapy.
Objectives: This study aimed to examine the cardiac effects of Adriamycin therapy based on Speckle-Tracking Echocardiography (STE) and early diagnosis of patients at risk of cardiotoxicity.
Patients and Methods: This study was conducted on 30 breast cancer patients (> 18 years old) who were treated with Adriamycin-based chemotherapy. Conventional echocardiography, STE, Electrocardiogram (ECG), and biochemical markers measurements (troponin I and CK-MB) were performed prior to and after chemotherapy. In addition, longitudinal strain analysis was performed via STE using automated functional imaging.
Results: Echocardiographic findings showed significant decreases in Ejection Fraction (EF) after the therapy. However, no significant differences were found regarding pulse rate, systolic and diastolic blood pressure, ECG changes, troponin I, and CK-MB after the therapy. Based on the global longitudinal strain, the longitudinal strain was significantly decreased in the patients after the therapy (-22.1 ± 2.1 prior to and -19 ± 2.2 after the therapy, P = 0.001).
Conclusions: Cardiotoxicity during the early phase of anthracycline treatment can be detected via STE prior to observation of systolic function deterioration by conventional echocardiography. In fact, anthracycline-induced cardiotoxicity can be observed much earlier via STE compared to conventional echocardiography.
 

Keywords

Cardiotoxicity,Anthracycline,Adriamycin

© 0, Shiraz University of Medical Sciences.

Fulltext

The full text is available in PDF.

 

References

  • 1.

    The references are available in PDF.

  • COMMENTS

    LEAVE A COMMENT HERE: